We Are Short $MAGH

A Cayman shell with fake “investors,” a collapsing business, related party transactions, a bogus contractor, and a $35M insider liquidation pipeline disguised as an IPO.

FULL REPORT: bmfreports.com/articles/magh 1. The $35 Million Insider Dump Loaded Into the IPO

MAGH pre-registered 8,804,400 insider shares — over $35 million at the IPO price — for immediate resale.
No lock-up.
No restrictions.
No capital to the company.
This wasn’t an offering. It was an exit.

Thread: BMF Reports is short $USAU.

Our work points to a financing-first model: serial promotions, persistent losses, and heavy dilution risk ahead. Free report below.
bmfreports.com/articles/usau 2/ Core issue: CK Gold requires ~$635M capex before first pour. USAU’s current tools (a $150M shelf + $40M ATM) don’t bridge the gap. Any path we model implies significant additional equity = dilution.

BMF Reports has released a new short report on $ATYR (aTyr Pharma).
Single-asset risk, dilution setup, and binary trial outcome ahead.
Full report: bmfreports.com/articles/atyr aTyr is a 20-year-old “platform” biotech with zero approved products.
The company now lives or dies on one drug: efzofitimod.

BMF Capital is SHORT NovaBay Pharmaceuticals $NBY

Another Lazar-touched microcap headed straight for the shell graveyard.
This isn’t innovation — it’s an insider money funnel.
Here’s why we’re short: NovaBay isn’t just a struggling biotech.
It’s become a staging ground for David Lazar — a known operator with a long track record of custodianship games, stealth takeovers, and toxic dilution.
This isn’t our first Lazar ticker. It won’t be our last.

Laser Photonics ($LASE) is collapsing — –48% since our report.
This is what happens when a “growth story” is really an insider cash funnel.
We warned. The filings confirmed it. The market’s catching up. Insider Control
ICT Investments + Fonon entities control 58.5% of shares.
Filings even disclose: “any distribution… must be distributed to an affiliate company.”
Translation: Shareholder money goes straight back to insiders.

New Short Report: Connexa Sports Technologies $YYAI

This isn’t a turnaround story. It’s a penny-stock hustle dressed up as a Nasdaq “AI” play. From pickleball gimmicks to love-bot algorithms. This company is the definition of desperation. Once upon a time, $YYAI was Slinger Bag – selling tennis ball launchers.
When that flopped, they pivoted to pickleball.
When that failed, they sold the whole business for $1. Yes—ONE dollar.

THREAD: We believe $ATHR is built on fraud, fake filings, and insiders violating securities laws.

After months of digging, we’re finally ready to expose the truth.

Here’s why we believe Aether Holdings ($ATHR) could be facing regulatory blowback. 👇 1. Lock-Up Violation = FRAUD
ATHR’s CEO Nicolas Lin agreed to a 6-month lock-up.
Same day as the IPO, a hidden filing allowed 428,572 shares to be dumped.
Who sold them?
→ A shell called 28 Ventures Aether
→ Run by... Nicolas Lin and Frank Cid

We Called It: INMB’s Alzheimer’s “Data” Is a Joke.

$INMB just dropped their Phase 2 MINDful results.

And guess what?

Still no peer-reviewed data. Still no statistical rigor. Still no signal.
Just vibes, charts, and Cohen’s d bars.

Let’s walk through the farce. 👇 1. They released another slide deck, not a paper.

Not peer-reviewed.
Not audited.
Not even preprinted.

Just a couple bar graphs dressed up like science — with effect sizes that wouldn’t move a mouse, let alone a market.